Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Intomics Enters €5.2M Personalized Cancer Diagnostic Project

Published: Thursday, June 06, 2013
Last Updated: Thursday, June 06, 2013
Bookmark and Share
Vejle Sygehus, DTU, Exiqon A/S, and Intomics A/S have joined forces.

The project will optimize treatment of cancer patients based on the cancers’ individual genetic fingerprint. Intomics will use its leading biomedical data analysis capabilities to help choose the right treatment from cancer-derived genetic information.

The project receives €3.0M in financial support from The Danish National Advanced Technology Foundation.

Two cancer patients may respond very differently to the same treatment if their genetic cancer fingerprints differ.

Mutations in genes participating in key cancer pathways and mechanisms may impact whether a given patient responds well to a treatment or not.

“By enhancing our understanding of the correlation between key mutations in cancer pathways and treatment outcome, we can better select the optimal treatment for each individual patient” says Thomas S. Jensen, CEO of Intomics A/S.

Vejle Sygehus, the Technical University of Denmark (DTU), Exiqon A/S, and Intomics A/S have joined forces to develop a future platform for precision medicine in a five-year project supported by The Danish National Advanced Technology Foundation.

The project will focus on colorectal cancer, where genetic information from many samples will be available.

Intomics A/S is developing sophisticated tools for analyzing and combining large quantities of biomedical data, including genetic variation data from individuals.

Based on these tools and Intomics’ unique expertise within molecular systems biology, genetic data derived from tumours will be analyzed and correlated with treatment outcome to advance the field of precision medicine.

Thomas S. Jensen continues, “We are very happy to be part of the project. I see a great synergy between the four partners and strongly believe that by teaming up with leading companies and research institutions in cancer research, data analysis, and diagnostic kit development, we can make important discoveries that can help cancer patients.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Systems Medicine – The Future Approach to Diseases
Review give insight into the future of understanding the body and its mechanisms through systems medicine.
Genetic Signature Linked to Cancer Prognosis Identified
The results of the analysis of 8,161 tissue samples could in the future help clinicians decide how best to treat a patient as well as aid the development of new targeted treatments.
Mapping the Human Immune System
Researchers try to harness supercomputers to create the first map of the human immune system.
Microsatellites Linked to Cancer
DNA repeat stretches, called microsatellites, play a greater role in cancer progression and survival that previously thought.
Universal Flu Vaccine Designed by Scientists
An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.
Faecal Bacteria Linked to Body Fat
Researchers at King’s College London have found a new link between the diversity of bacteria in human poo – known as the human faecal microbiome - and levels of abdominal body fat.
NCI Collaborates with Multiple Myeloma Research Foundation
NCI collaborates with MMRF to incorporate genomic and clinical data into NCI Genomic Data Commons database.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos